Anavex Life Sciences Stock Performance
| AVXL Stock | USD 3.68 0.10 2.65% |
The firm shows a Beta (market volatility) of 3.51, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Anavex Life will likely underperform. Anavex Life Sciences has an expected return of -0.83%. Please make sure to confirm Anavex Life Sciences potential upside, and the relationship between the jensen alpha and rate of daily change , to decide if Anavex Life Sciences performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Anavex Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in May 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
Actual Historical Performance (%)
One Day Return 2.17 | Five Day Return (7.16) | Year To Date Return (37.85) | Ten Year Return 147.37 | All Time Return (53.00) |
Last Split Factor 1:4 | Last Split Date 2015-10-07 |
1 | Acquisition by Athanasios Skarpelos of 50000 shares of Anavex Life at 5.36 subject to Rule 16b-3 | 02/20/2024 |
2 | Robbins LLP Reminds Investors to Seek Counsel in the Class Action Against Anavex Life Sciences Corporation | 04/05/2024 |
3 | Shareholders of Anavex Life Sciences Corporation Should Contact Levi Korsinsky Before May 13, 2024 to Discuss Your Rights - AVXL | 04/09/2024 |
4 | Levi Korsinsky Reminds Anavex Life Sciences Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL | 04/12/2024 |
5 | ProtoKinetix CEO Clarence Smith buys 35,000 in company stock | 04/16/2024 |
6 | Anavex Life Sciences Corporation Securities Fraud Class Action Lawsuit Pending Contact Levi Korsinsky Before May 13, 2024 to Discuss Your Rights - AVXL | 04/17/2024 |
7 | INVESTOR ACTION ALERT The Schall Law Firm Encourages Investors in Anavex Life Sciences Corp. with Losses of 100,000 to Contact the Firm | 04/19/2024 |
8 | Levi Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit AVXL | 04/22/2024 |
| Begin Period Cash Flow | 149.2 M |
Anavex |
Anavex Life Relative Risk vs. Return Landscape
If you would invest 658.00 in Anavex Life Sciences on January 24, 2024 and sell it today you would lose (290.00) from holding Anavex Life Sciences or give up 44.07% of portfolio value over 90 days. Anavex Life Sciences is currently does not generate positive expected returns and assumes 4.1664% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than Anavex, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Anavex Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Anavex Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Anavex Life Sciences, and traders can use it to determine the average amount a Anavex Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1997
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AVXL |
Estimated Market Risk
| 4.17 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.83 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.2 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Anavex Life is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Anavex Life by adding Anavex Life to a well-diversified portfolio.
Anavex Life Fundamentals Growth
Anavex Stock prices reflect investors' perceptions of the future prospects and financial health of Anavex Life, and Anavex Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Anavex Stock performance.
| Return On Equity | -0.32 | ||||
| Return On Asset | -0.21 | ||||
| Current Valuation | 166.62 M | ||||
| Shares Outstanding | 82.11 M | ||||
| Price To Earning | (11.03) X | ||||
| Price To Book | 2.60 X | ||||
| EBITDA | (47.5 M) | ||||
| Net Income | (47.51 M) | ||||
| Cash And Equivalents | 149.16 M | ||||
| Cash Per Share | 1.91 X | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 14.95 X | ||||
| Book Value Per Share | 1.65 X | ||||
| Cash Flow From Operations | (27.79 M) | ||||
| Earnings Per Share | (0.54) X | ||||
| Market Capitalization | 302.17 M | ||||
| Total Asset | 154.39 M | ||||
| Retained Earnings | (293.07 M) | ||||
| Working Capital | 141.85 M | ||||
| Current Asset | 9.45 M | ||||
| Current Liabilities | 3.19 M | ||||
About Anavex Life Performance
To evaluate Anavex Life Sciences Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Anavex Life generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Anavex Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Anavex Life Sciences market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Anavex's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.00 | 0.00 | |
| Return On Tangible Assets | (0.28) | (0.29) | |
| Return On Capital Employed | (0.39) | (0.37) | |
| Return On Assets | (0.28) | (0.29) | |
| Return On Equity | (0.39) | (0.40) |
Things to note about Anavex Life Sciences performance evaluation
Checking the ongoing alerts about Anavex Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Anavex Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Anavex Life Sciences generated a negative expected return over the last 90 days | |
| Anavex Life Sciences has high historical volatility and very poor performance | |
| Anavex Life Sciences has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (47.51 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Anavex Life Sciences currently holds about 149.16 M in cash with (27.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.91. | |
| Latest headline from accesswire.com: Levi Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit AVXL |
- Analyzing Anavex Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Anavex Life's stock is overvalued or undervalued compared to its peers.
- Examining Anavex Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Anavex Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Anavex Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Anavex Life's stock. These opinions can provide insight into Anavex Life's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anavex Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Anavex Stock analysis
When running Anavex Life's price analysis, check to measure Anavex Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anavex Life is operating at the current time. Most of Anavex Life's value examination focuses on studying past and present price action to predict the probability of Anavex Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anavex Life's price. Additionally, you may evaluate how the addition of Anavex Life to your portfolios can decrease your overall portfolio volatility.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Anavex Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.54) | Return On Assets (0.21) | Return On Equity (0.32) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.